FLI1 and EWS-FLI1 function as ternary complex factors and ELK1 and SAP1a function as ternary and quaternary complex factors on the Egr1 promoter serum response elements

Oncogene

Volumn 14, Issue 2, 1997, Pages 213-221

  Watson, Dennis K ^a   Robinson, Lois ^b   Hodge, David R ^b   Kola, Ismail ^c   Papas, Takis S ^a   Seth, Arun ^d,e  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF TORONTO   (Canada)

^e WOMEN S COLLEGE HOSPITAL   (Canada)

Author keywords

CArG box; Egr1; ETS; EWS FLI1; FLI1; Quaternary complex factor (QCF); SRE; Ternary complex factor (TCF)

Indexed keywords

CIS ACTING ELEMENT; DNA BINDING PROTEIN; TRANSCRIPTION FACTOR;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; SEQUENCE HOMOLOGY; STRUCTURE ACTIVITY RELATION; TRANSCRIPTION REGULATION;

ANIMALIA;

EID: 0031022241     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1200839     Document Type: Article

References (49)

1. Ascione R, Thompson DM, Thomas R, Panayiotakis A, Ramsay R, Tymms M, Kola I and Seth A. (1992). Int. J. Oncol., 1, 631-637.
2. Bailly RA, Bosselut R, Zucman J, Cormier F, Delattre O, Roussel M, Thomas G and Ghysdael J. (1994). Mol. Cell. Biol., 14, 3230-3241.
3. Bhat NK, Fischinger PJ, Seth A, Watson DK and Papas TS. (1996). International J. Oncology, 8, 841-846.
4. Christy BA, Lau LF and Nathans D. (1988). Proc. Natl. Acad. Sci. USA, 85, 7857-7861.
5. Coleman DL, Bartiss AH, Sukhatme VP, Liu J and Rupprecht HD. (1992). J. Immunology, 149, 3045-3051.
6. Dalton S and Treisman R. (1992). Cell, 68, 597-612.
7. DeFranco C, Damon DH, Endoh M and Wagner JA. (1993). Mol. Endocrinol., 7, 365-379.
8. Delattre O, Zucman J, Plougastel B, Desmaze C, Melot T, Peter M, Kovar H, Joubert J, de Jong P, Rouleau G et al. (1992). Nature, 359, 162-165.
9. Donaldson LW, Peterson JM, Graves BJ and McIntosh LP. (1994). Biochem., 33, 13509-13516.
10. Hipskind RA, Rao VN, Mueller CG, Reddy ES and Nordheim A. (1991). Nature, 354, 531-534.
11. Janknecht R and Nordheim A. (1993). Biochim. Biophys. Acta, 1155, 346-356.
12. Kharbanda S, Saleem A, Hirano M, Emoto Y, Sukhatme V, Blenis J and Kufe D. (1994). Cell Growth Diff., 5, 259-265.
13. Koizumi S, Fisher RJ, Fujiwara S, Jorcyk C, Bhat NK, Seth A and Papas TS. (1990). Oncogene, 5, 675-681.
14. Kola I, Brookes S, Green AR, Garber R, Tymms M, Papas TS and Seth A. (1993). Proc. Natl. Acad. Sci. USA, 90, 7588-7592.
15. La Marco K, Thompson CC, Byers BP, Walton EM and McKnight SL. (1991). Science, 253, 789-792.
16. Latinkic BV and Lau LF. (1994). J. Biol. Chem., 269, 23163-23170.
17. Lautenberger JA, Burdett LA, Gunnell MA, Qi S, Watson DK, O'Brien SJ and Papas TS. (1992). Oncogene, 7, 1713-1719.
18. Lessnick SJ, Braun BS, Denny CT and May WA. (1995). Oncogene, 10, 423-431.
19. Liang H, Olejniczak ET, Mao X, Nettesheim DG, Yu L, Thompson CB and Fesik SW. (1994). Proc. Natl. Acad. Sci. USA, 91, 11655-11659.
20. Mao X, Miesfeldt S, Yang H, Leiden JM and Thompson CB. (1994). J. Biol. Chem., 269, 18216-18222.
21. Maroulakou IG, Papas TS and Green JE. (1994). Oncogene, 9, 1551-1565.
22. May WA, Lessnick SL, Braun BS, Klemsz M, Lewis BC, Lunsford LB, Hromas R and Denny CT. (1993). Mol. Cell. Biol., 13, 7393-7398.
23. McMahon SB and Monroe JG. (1995). Mol. Cell. Biol., 15, 1086-1093.
24. Milbrandt J. (1987). Science, 238, 797-799.
25. Nguyen HQ, Hoffman-Liebermann B and Liebermann DA. (1993). Cell, 72, 197-209.
26. Nye JA, Petersen JM, Gunther CV, Jonsen MD and Graves BJ. (1992). Genes Dev., 6, 975-990.
27. Ohno T, Rao VN and Reddy ES. (1993). Cancer Res., 53, 5859-5863.
28. Perez-Castillo A, Pipaon C, Garcia I and Alemany S. (1993). J. Biol. Chem., 268, 19445-19450.
29. Price MA, Rogers AE and Treisman R. (1995). EMBO J., 14, 2589-2601.
30. Qi S, Chen ZQ, Papas TS and Lautenberger JA. (1992). DNA Seq., 3, 127-129.
31. Robinson L, Thompson D and Seth A. (1995). Miami Short Reports, 6, 76.
32. Sakamoto KM, Fraser JK, Lee HJ, Lehman E and Gasson JC. (1994). Mol. Cell. Biol., 14, 5975-5985.
33. Scth A, Ascione R, Fisher RJ, Mavrothalassitis GJ, Bhat NK and Papas TS. (1992). Cell Growth Differ., 3, 327-334.
34. Seth A, Hodge DR, Thompson DM, Robinson L, Panayiotakis A, Watson DK and Papas TS. (1993a). Aids Res. Hum. Retroviruses, 9, 1017-1023.
35. Seth A and Papas TS. (1990). Oncogene, 5, 1761-1767.
36. Seth A, Robinson L, Panayiotakis A, Thompson DM, Hodge DR, Zhang XK, Watson DK, Ozato K and Papas TS. (1994). Oncogene, 9, 469-477.
37. Seth A, Robinson L, Thompson DM, Watson DK and Papas TS. (1993b). Oncogene, 8, 1783-1790.
38. Seth A, Watson DK, Blair DG and Papas TS. (1989). Proc. Natl. Acad. Sci. USA, 86, 7833-7837.
39. Sukhatme VP, Cao SM, Chang LC, Tsai-Morris CH, Stamenkovick D, Ferreira PC, Cohen DR, Edwards SA, Shows TB, Curran T, Le Beau M and Adamson E. (1988). Cell, 53, 37-43.
40. Sumarsono SH, Wilwon TJ, Tymms MJ, Venter DJ, Corrick CM, Kola R, Lahoud MH, Papas TS, Seth A and Kola I. (1996). Nature, 379, 534-538.
41. Suva LJ, Ernst M and Rodan GA. (1991). Mol. Cell. Biol., 11, 2503-2510.
42. Topol LZ, Tatosyan AG. Ascione R, Thompson DM, Blair DG, Kola I and Seth A. (1992). Cancer Lett., 67, 71-78.
43. Tsai-Morris C-H, Cao X and Sukhatme VP. (1988). Nucl. Acids Rex., 16, 8835-8846.
44. Wasylyk B, Hahn SL and Giovane A. (1993). Eur. J. Biochem., 211, 7-18.
45. Watson DK, Ascione R and Papas TS. (1990). Crit. Rev. Oncog., 1, 409-436.
46. Watson DK, McWilliams MJ, Lapis P, Lautenbergcr JA, Schweinfest CW and Papas TS. (1988). Proc. Natl. Acad. Sci. USA, 85, 7862-7866.
47. Watson DK, Smyth FE, Thompson DM, Cheng JQ, Testa JR, Papas TS and Scth A. (1992). Cell Growth Differ., 3, 705-713.
48. Werner MH, Clore GM, Fisher CL, Fisher RJ, Trinh L, Shiloach J and Gronenborn AM. (1995). Cell, 83, 761-771.
49. Zhang X-K, Papas TS, Bhat NK and Watson DK. (1995). Hybridoma, 14, 563-569.